To better support the global study, Sequanta Technologies, as the only service provider in China who has been awarded the Platinum badge, has conducted concordance validation with Olink U.S. laboratory. The results showed that it had a high level of consistency between the two laboratories.
Strict and efficient laboratory management ensures high quality data output. The intra- and inter-run coefficients of variation (CV) of Olink assays are lower than the official limits (Intra-CV < 15%, Inter-CV < 25%).
Sequanta Technologies has expanded its capabilities by introducing both the NGS platform (Explore384/3072) and the qPCR platform (Target 96/48), making it the first service provider in China with a dual detection platform.
Sequanta has successfully analyzed over 20,000 samples for different projects. These samples encompass a wide range of types, including human plasma, serum, tissue lysates, cell lysates, exosomes, as well as mouse and non-human primate samples.